Prolactinomas account for 40–57% of all adenomas, followed by nonfunctional adenomas (28–37%), growth hormone-releasing adenomas (11–13%), and adrenocorticotropic hormone (ACTH)-related adenomas. Here, GH1 is linked to adenoma.